The Chemours Company (NYSE:CC) Given Average Recommendation of “Moderate Buy” by Analysts
The Chemours Company (NYSE:CC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month […]
The Chemours Company (NYSE:CC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month […]
